Reply to Liao : SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.
作者信息
Runnstrom Martin C, Lee F Eun-Hyung
机构信息
Department of Medicine Emory University Atlanta, Georgia.
出版信息
Am J Respir Crit Care Med. 2022 Sep 1;206(5):647-648. doi: 10.1164/rccm.202205-0979LE.
Abstract
摘要
相似文献
1
Reply to Liao : SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.对廖的回复：接受生物治疗的哮喘患者对SARS-CoV-2 mRNA疫苗的抗体反应：一项真实世界分析。
Am J Respir Crit Care Med. 2022 Sep 1;206(5):647-648. doi: 10.1164/rccm.202205-0979LE.
2
SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.接受生物治疗的哮喘患者对SARS-CoV-2 mRNA疫苗的抗体反应：一项真实世界分析
Am J Respir Crit Care Med. 2022 Sep 1;206(5):644-648. doi: 10.1164/rccm.202203-0599LE.
3
Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis.慢性疾病中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗抗体反应受损：一项真实世界分析
Chest. 2022 Jun;161(6):1490-1493. doi: 10.1016/j.chest.2021.12.654. Epub 2022 Jan 10.
4
Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy.mRNA 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫在接受生物治疗的重症哮喘患者中的有效性和持久性。
Front Immunol. 2022 May 20;13:892277. doi: 10.3389/fimmu.2022.892277. eCollection 2022.
5
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对单剂SARS-CoV-2 mRNA疫苗的抗体反应。
Ann Rheum Dis. 2021 Aug;80(8):1098-1099. doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.
6
Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?血液透析患者对 SARS-CoV-2 疫苗的抗体反应：灭活疫苗有效吗？
Ther Apher Dial. 2022 Aug;26(4):769-774. doi: 10.1111/1744-9987.13752. Epub 2021 Nov 16.
7
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia.对依赖输血的地中海贫血患者，AB0 血型对 BNT162b2 新型冠状病毒疫苗 mRNA 抗体反应无影响。
Acta Biomed. 2022 May 11;93(2):e2022134. doi: 10.23750/abm.v93i2.12819.
8
Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine.在首次接种BNT162b2 mRNA疫苗后早期感染新型冠状病毒2的个体中的抗体反应。
J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.008. Epub 2021 Aug 8.
9
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.在首次发生免疫性血小板减少性紫癜后成功进行mRNA SARS-CoV-2疫苗再次接种。
Platelets. 2022 May 19;33(4):652-653. doi: 10.1080/09537104.2022.2044463. Epub 2022 Feb 28.
10
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis.系统性硬化症成年患者对 BNT162b2 新冠病毒 mRNA 疫苗的抗体反应。
Clin Rheumatol. 2022 Sep;41(9):2755-2763. doi: 10.1007/s10067-022-06219-7. Epub 2022 May 26.
本文引用的文献
1
Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma.接受生物疗法治疗哮喘的患者中COVID-19疫苗反应降低。
Am J Respir Crit Care Med. 2022 May 15;205(10):1243-1245. doi: 10.1164/rccm.202111-2496LE.
2
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection.BNT162b2 mRNA疫苗接种或SARS-CoV-2感染后抗体滴度衰减的大规模研究
Vaccines (Basel). 2021 Dec 31;10(1):64. doi: 10.3390/vaccines10010064.
3
Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.BNT162b2 和 mRNA-1273 两种 SARS-CoV-2 疫苗接种后的 IgG 抗体反应差异。
Microbiol Spectr. 2021 Dec 22;9(3):e0116221. doi: 10.1128/Spectrum.01162-21. Epub 2021 Nov 10.
4
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.接种BNT162b2和mRNA-1273后新型冠状病毒2型抗体反应的比较
JAMA. 2021 Oct 19;326(15):1533-1535. doi: 10.1001/jama.2021.15125.
5
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.新冠病毒mRNA-1273疫苗第二剂接种后6个月的抗体持久性
N Engl J Med. 2021 Jun 10;384(23):2259-2261. doi: 10.1056/NEJMc2103916. Epub 2021 Apr 6.
6
The cellular and humoral immune response to influenza vaccination is comparable in asthmatic and healthy subjects.哮喘患者与健康受试者对流感疫苗的细胞和体液免疫应答相当。
Hum Vaccin Immunother. 2021 Jan 2;17(1):98-105. doi: 10.1080/21645515.2020.1759995. Epub 2020 May 21.
7
Relationship between asthma status and antibody response pattern to 23-valent pneumococcal vaccination.哮喘状态与23价肺炎球菌疫苗抗体反应模式之间的关系。
J Asthma. 2020 Apr;57(4):381-390. doi: 10.1080/02770903.2019.1575394. Epub 2019 Feb 20.
8
Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial.在患有中度至重度哮喘的青少年和年轻成年患者中，贝那利珠单抗不会损害对季节性流感疫苗的抗体反应：IIIb期ALIZE试验结果
J Asthma Allergy. 2018 Nov 20;11:181-192. doi: 10.2147/JAA.S172338. eCollection 2018.
9
Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis.度普利尤单抗不影响疫苗诱导免疫的相关因素：一项在中重度特应性皮炎成人中进行的随机、安慰剂对照试验。
J Am Acad Dermatol. 2019 Jan;80(1):158-167.e1. doi: 10.1016/j.jaad.2018.07.048. Epub 2018 Aug 6.
10
Influence of asthma status on serotype-specific pneumococcal antibody levels.哮喘状态对血清型特异性肺炎球菌抗体水平的影响。
Postgrad Med. 2010 Sep;122(5):116-24. doi: 10.3810/pgm.2010.09.2208.
Zotero 插件